Healthcare provider profile · identity verified

Joseph Aquilina, FNPC

Nurse Practitioner · MILLINOCKET, ME · NPI 1104835669

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	483	128
Atorvastatin Calcium	Atorvastatin Calcium	482	139
Amlodipine Besylate	Amlodipine Besylate	333	93
Losartan Potassium	Losartan Potassium	285	76
Levothyroxine Sodium	Levothyroxine Sodium	270	68
Metoprolol Tartrate	Metoprolol Tartrate	248	73
Metformin Hcl	Metformin Hcl	228	64
Pantoprazole Sodium	Pantoprazole Sodium	219	62
Omeprazole	Omeprazole	211	63
Metoprolol Succinate	Metoprolol Succinate	208	58
Rosuvastatin Calcium	Rosuvastatin Calcium	185	62
Simvastatin	Simvastatin	154	42
Gabapentin	Gabapentin	147	37
Eliquis	Apixaban	139	32
Hydrochlorothiazide	Hydrochlorothiazide	132	39
Albuterol Sulfate Hfa	Albuterol Sulfate	130	52
Tamsulosin Hcl	Tamsulosin Hcl	128	41
Furosemide	Furosemide	126	45
Chlorthalidone	Chlorthalidone	111	39
Allopurinol	Allopurinol	87	21
Trazodone Hcl	Trazodone Hcl	80	23
Potassium Chloride	Potassium Chloride	79	21
Alendronate Sodium	Alendronate Sodium	74	23
Pravastatin Sodium	Pravastatin Sodium	72	19
Prednisone	Prednisone	71	43
Sertraline Hcl	Sertraline Hcl	69	21
Paroxetine Hcl	Paroxetine Hcl	67	20
Carvedilol	Carvedilol	62	19
Spironolactone	Spironolactone	59	14
Duloxetine Hcl	Duloxetine Hcl	54	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	12
Metformin Hcl Er	Metformin Hcl	53	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Bupropion Xl	Bupropion Hcl	48	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	15
Finasteride	Finasteride	47	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	13
Montelukast Sodium	Montelukast Sodium	46	13
Oxybutynin Chloride	Oxybutynin Chloride	46	suppressed
Glipizide	Glipizide	45	13
Famotidine	Famotidine	44	15
Lovastatin	Lovastatin	42	13
Warfarin Sodium	Warfarin Sodium	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Ezetimibe	Ezetimibe	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	11
Triamcinolone Acetonide	Triamcinolone Acetonide	41	23
Tramadol Hcl	Tramadol Hcl	39	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	18
Citalopram Hbr	Citalopram Hydrobromide	36	11
Fluoxetine Hcl	Fluoxetine Hcl	36	11
Ozempic	Semaglutide	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Alprazolam	Alprazolam	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Jardiance	Empagliflozin	33	suppressed
Spiriva Respimat	Tiotropium Bromide	33	suppressed
Glipizide Er	Glipizide	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	15
Quetiapine Fumarate	Quetiapine Fumarate	32	11
Atenolol	Atenolol	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Pregabalin	Pregabalin	31	12
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Sotalol	Sotalol Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Cephalexin	Cephalexin	26	17
Meloxicam	Meloxicam	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	22
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Azithromycin	Azithromycin	24	23
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Rybelsus	Semaglutide	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Lorazepam	Lorazepam	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Amoxicillin	Amoxicillin	20	17
Baclofen	Baclofen	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Fentanyl	Fentanyl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Valsartan	Valsartan	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Ofloxacin	Ofloxacin	12	12
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Acyclovir	Acyclovir	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error